Post-COVID, the seasonal flu has become more unpredictable and severe, with rising hospitalisations, complex complications, ...

Background There are no evidence-based recommendations for surfactant use in late preterm (LPT) and term infants with respiratory distress syndrome (RDS). Objective To investigate the safety and ...

A recent study has identified new lineages of human metapneumovirus (hMPV) — A2.2.1 and A2.2.2, highlighting its significant prevalence among children in Puducherry, India. Notable outbreaks ...

The reason behind acute respiratory distress syndrome development in some patients suffering with severe respiratory illness and not others is unknown, but recent research suggests a possible ...

Previous research on neonatal respiratory distress syndrome (NRDS) in premature infants found that it could be treated by introducing replacement lung surfactant, but that was not the case in adults.

Evolution of interfacial mechanics of lung surfactant mimics progression of acute respiratory distress syndrome. Proceedings of the National Academy of Sciences , 2023; 120 (51) DOI: 10.1073/pnas ...

Acute respiratory distress syndrome causes fluid to leak into your lungs, keeping oxygen from getting to your organs. Learn more about the causes, risk factors, symptoms, complications, diagnosis ...

Minimally invasive surfactant therapy did not reduce a composite outcome of death and neurodevelopmental disability before age 2 years among preterm infants with respiratory distress syndrome who ...

Changes in your baby or toddler's breathing rhythm may indicate respiratory distress and require rapid medical intervention. Friday, September 6 2024 Facebook ...